VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | The importance of genomic testing in MPNs and other myeloid malignancies

Rafael Bejar, MD, PhD, University of California San Diego, San Diego, CA, shares some insights into the importance of genomic testing in myeloproliferative neoplasms (MPNs) and other myeloid malignancies, and further discusses the value of testing patients for clonal hematopoiesis of indeterminate potential (CHIP). This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Disclosures

Aptose Biosciences – employment and equity
Gilead – data safety monitoring committees chair
Epizyme – data safety monitoring committee chair
BMS – ad hoc advisory board honoraria, research funding
Takeda – research funding

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter